[Evaluation of immunostimulating agents used in pulmonologic practice].
Several immunostimulating drugs--levamisole (decaris), Gamma-A, dipyridamole (Antistenocardin), Respivax--were included in the treatment of 161 patients with frequently recurring chronic nonspecific lung diseases and data for suppression of various components of the immune system. Levamisole and Respivax show marked antirelapse efficacy in chronic lung diseases. Gamma-A has a certain immunosubstituent action, dipyridamole exerts a moderate antirelapse action.
Kis'ova
K
K
Zlatanov
Z
Z
Peneva
M
M
Iankov
K
K
Tsonev
A
A
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001428:Bacterial Vaccines; D002908:Chronic Disease; D004176:Dipyridamole / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007070:Immunoglobulin A / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy* / Q000276:immunology; D012008:Recurrence; D005719:gamma-Globulins / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D007070:Immunoglobulin A; C060964:gamma-A; D005719:gamma-Globulins; C060965:respivax; D007978:Levamisole; D004176:Dipyridamole
Otsenka na niakoi imunostimulirashti sredstva, prilagani v pulmologichnata praktika.